Melanin-Concentrating Hormone (MCH) neurons are a discrete population of neurons located primarily in the lateral hypothalamus and zona incerta, projecting widely throughout the CNS to regulate feeding, energy homeostasis, sleep-wake cycles, and emotional processing[1]. MCH is a cyclic 19-amino acid neuropeptide derived from the 165-amino acid precursor prepro-MCH (pmch gene), which is cleaved to yield MCH and two additional peptides: neuropeptide EI (NPEI) and neuropeptide GE (NPGE)[2].
MCH neurons are increasingly recognized for their involvement in the hypothalamic dysfunction observed in neurodegenerative diseases, particularly Parkinson's disease and Alzheimer's disease, where sleep disorders and metabolic changes are prominent non-motor symptoms.
MCH neurons are concentrated in two primary brain regions:
| Region | Description |
|---|---|
| Incertal zone (ZI) | Densest population, extends through the subthalamic region |
| Lateral hypothalamus (LH) | More rostral distribution, overlapping with orexin neurons |
MCH neurons receive inputs from:
MCH neurons project to:
The pmch gene on chromosome 5 (mouse) encodes prepro-MCH:
prepro-MCH (165 AA)
├── Signal peptide (1-19)
├── NPEI (20-54) — neuropeptide EI
├── MCH (55-84) — active peptide (19 AA)
└── NPGE (109-165) — neuropeptide GE
| Receptor | Gene | Coupling | Distribution | Function |
|---|---|---|---|---|
| MCHR1 | MCHR1 | Gi/o | Widespread (CNS, periphery) | Primary MCH receptor |
| MCHR2 | MCHR2 | Gs/Gq | Limited (human CNS) | Secondary receptor |
MCHR1 is the dominant receptor in rodents and mediates most MCH functions. MCHR2 is present in humans but largely absent in rodents, complicating translational research.
MCHR1 activation recruits:
MCH neurons exhibit state-dependent activity patterns:
| State | Firing Rate | Notes |
|---|---|---|
| Awake (fed) | 2-4 Hz | Regular activity |
| Awake (fasting) | 4-6 Hz | Increased firing |
| NREM sleep | 0.5-1 Hz | Reduced activity |
| REM sleep | 3-5 Hz | Active[3] |
MCH neurons make primarily excitatory (glutamatergic) synaptic contacts:
MCH neurons are critical for sleep-wake regulation, particularly REM sleep:
MCH neurons are most active during REM sleep[3:1]:
| Effect | Mechanism |
|---|---|
| Increased REM duration | Direct promotion of REM-generating circuits |
| Enhanced sleep continuity | Reduced wake fragmentation |
| Circadian phase shifting | MCH influences circadian clock genes |
MCH dysfunction may contribute to narcolepsy:
MCH neurons are affected in Parkinson's disease, contributing to multiple non-motor symptoms:
Alzheimer's disease patients show profound sleep-wake cycle disturbances:
MCHR1 antagonists have been investigated for:
| Indication | Compound | Stage |
|---|---|---|
| Obesity | BMS-986020, NBI-75629 | Phase I/II (discontinued) |
| Depression/anxiety | Various | Preclinical |
| Cognitive enhancement | MCH1R antagonists | Research |
MCHR1 agonists may have therapeutic potential:
| Indication | Mechanism |
|---|---|
| REM sleep disorders | Promote REM through MCH activation |
| Cognitive enhancement | MCH improves memory consolidation |
| Neuroprotection | MCHR1 activation has anti-inflammatory effects |
Current investigation focuses on:
Bittencourt JC. The melanin-concentrating hormone system: an overview. Peptides. 2023. ↩︎
Nahon JL. The melanin-concentrating hormone: from melanin concentrating hormone to biological functions. Vitamins and Hormones. 2006. ↩︎
Torterolo P, Lagos P, Monti JM. Melanin-concentrating hormone: a sleep-promoting peptide. International Journal of Molecular Sciences. 2021. ↩︎ ↩︎